Mitral valvulitis as a severe extra-articular manifestation of rheumatoid arthritis: a case report

被引:1
作者
Frederiksen, Anne Sofie [1 ]
Jorgensen, Steen Hylgaard [1 ,2 ,3 ]
Wiggers, Henrik [1 ,2 ]
Hauge, Ellen-Margrethe [2 ,4 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
[2] Aarhus Univ, Dept Clin Med, Palle Juul Jensens Blvd 82, DK-8200 Aarhus N, Denmark
[3] North Denmark Reg Hosp, Dept Cardiol, Bispensgade 37, DK-9800 Hjorring, Denmark
[4] Aarhus Univ Hosp, Dept Rheumatol, Palle Juul Jensens Blvd 59, DK-8200 Aarhus N, Denmark
关键词
Echocardiography; Autoimmune disease; Endocarditis; Valvulitis; Mitral regurgitation; Complication; Case report; INVOLVEMENT;
D O I
10.1093/ehjcr/ytaa467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Extra-articular manifestations (EAMs) are common in patients with rheumatoid arthritis (RA). Cardiac EAMs are rare but may cause complete heart block and damage to the heart valves. Case summary We present the case of a middle-aged woman with long-standing RA and EAMs as the most prominent symptoms. The patient experienced complete atrioventricular heart block and developed nodular vegetations affecting the mitral valve, ultimately leading to severe mitral regurgitation and valve replacement. Discussion The diagnosis of cardiac EAMs in RA may be challenging for the clinicians. Symptoms and findings may mimic more common conditions such as malignancy and infectious endocarditis. A multidisciplinary approach is of paramount importance in order to make an early diagnosis and to provide optimal treatment to patients with RA and cardiac complications.
引用
收藏
页数:6
相关论文
共 12 条
[1]  
Aslam F, 2018, BMJ CASE REP, V2018
[2]   Elevated Serum IgG4 Defines Specific Clinical Phenotype of Rheumatoid Arthritis [J].
Chen, Le-Feng ;
Mo, Ying-Qian ;
Ma, Jian-Da ;
Luo, Ling ;
Zheng, Dong-Hui ;
Dai, Lie .
MEDIATORS OF INFLAMMATION, 2014, 2014
[3]   Cardiac involvement in rheumatoid disease [J].
Kitas, G ;
Banks, MJ ;
Bacon, PA .
CLINICAL MEDICINE, 2001, 1 (01) :18-21
[4]  
Lagrutta M, 2016, REUMATOL CLIN, V12, P223, DOI [10.1016/j.reumae.2016.04.001, 10.1016/j.reuma.2015.07.006]
[5]   IgG4-related disease: current challenges and future prospects [J].
Lang, David ;
Zwerina, Jochen ;
Pieringer, Herwig .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 :189-199
[6]   Rheumatoid arthritis: A review of the cutaneous manifestations [J].
Sayah, A ;
English, JC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (02) :191-209
[7]   Rheumatoid arthritis [J].
Scott, David L. ;
Wolfe, Frederick ;
Huizinga, Torn W. J. .
LANCET, 2010, 376 (9746) :1094-1108
[8]   Epidemiology of extra-articular manifestations in rheumatoid arthritis [J].
Turesson, C ;
Jacobsson, LTH .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (02) :65-72
[9]   Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis [J].
Turesson, C. ;
Jacobsson, L. T. H. ;
Sturfelt, G. ;
Matteson, E. L. ;
Mathsson, L. ;
Ronnelid, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (01) :59-64
[10]  
Turesson C, 2002, J RHEUMATOL, V29, P62